Effectiveness of Combined 131I-chTNT and Radiofrequency Ablation Therapy in Treating Advanced Hepatocellular Carcinoma
Authors:
- 8 October 2014
- journal article
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 71 (2) , 777-784
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Combining Transarterial Chemoembolization With Radiofrequency Ablation for Hepatocellular Carcinoma: One Step Forward?Journal of Clinical Oncology, 2013
- Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized TrialJournal of Clinical Oncology, 2013
- A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinomaJournal of Hepatology, 2012
- Local-Regional Treatment of Hepatocellular CarcinomaRadiology, 2012
- Current Approaches to the Treatment of Early Hepatocellular CarcinomaThe Oncologist, 2010
- Chemoembolization for Hepatocellular Carcinoma: Comprehensive Imaging and Survival Analysis in a 172-Patient CohortRadiology, 2010
- In-Line Radiolabeling: A Novel Continuous-Flow System for Commercial-Scale Protein LabelingJournal of Nuclear Medicine, 2009
- Radioimmunotherapy prevents local recurrence of colonic cancer in an experimental modelBritish Journal of Surgery, 2009
- 131 I-chTNT Radioimmunotherapy of 43 Patients with Advanced Lung CancerCancer Biotherapy and Radiopharmaceuticals, 2006
- Pivotal Study of Iodine-131–Labeled Chimeric Tumor Necrosis Treatment Radioimmunotherapy in Patients With Advanced Lung CancerJournal of Clinical Oncology, 2005